GRAFTECH INTERNATIONAL LTD. - 10-Q Summary (Q1 2006)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for GrafTech International Ltd. for the period ended March 31, 2006. The company operates in two primary segments: Synthetic Graphite (graphite electrodes, cathodes, advanced materials) and Other (natural graphite, carbon electrodes, refractories). The company is a large accelerated filer incorporated in Delaware.
Key Financial Metrics
| Metric (in thousands) | Q1 2006 | Q1 2005 |
|---|---|---|
| Net Sales | $208,588 | $211,094 |
| Gross Profit | $55,931 | $48,654 |
| Gross Margin | 26.8% | 23.0% |
| Net Income (Loss) | $(4,646) | $1,505 |
| Diluted EPS | $(0.05) | $0.02 |
| Cash and Equivalents | $21,301 | $15,498 |
| Total Debt | $763,130 | $704,148 |
| Operating Cash Flow | $(33,367) | $(13,790) |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 1.2% to $208.6 million. The Synthetic Graphite segment saw a 1.7% increase driven by higher cathode and advanced material sales, while the Other segment declined 21.9% due to timing of refractory shipments and lower carbon electrode volumes.
- Profitability: Despite lower sales, Gross Profit increased 14.8% to $55.9 million due to improved pricing in graphite electrodes and lower volumes in lower-margin products. However, the company reported a Net Loss of $4.6 million compared to Net Income of $1.5 million in Q1 2005.
- Unusual Items: The loss was significantly impacted by a $8.151 million impairment loss on long-lived assets (primarily ERP system write-offs and asset sales) and $2.946 million in restructuring charges. Interest expense increased to $14.2 million due to higher average debt levels.
- Currency: The company recorded a $2.6 million currency gain in Q1 2006, reversing a $6.6 million loss in the prior year period, largely due to Euro-denominated intercompany loans.
Guidance, Outlook, and Risks
- 2006 Outlook: Management expects graphite electrode sales volume of 210,000–215,000 metric tons. Revenue is projected to increase 15% in 2006, with most growth in the second half. Production cost increases are expected to be contained to 10–12%.
- Financial Estimates: Capital expenditures are estimated at $45 million; depreciation at $40 million. The effective tax rate for 2006 is expected to be 37–40%.
- Liquidity: The company remains highly leveraged with total debt of $763.1 million. It maintains a Revolving Facility with $124.1 million available. Management expects to remain in compliance with financial covenants for the next 12 months.
- Risks: Key risks include high leverage, volatility in raw material costs (premium needle coke), currency exchange fluctuations, and the potential for additional antitrust investigations or lawsuits. A securities class action filed in March 2006 was voluntarily withdrawn by plaintiffs.
Investor Verification Checklist
- Debt Covenants: Verify continued compliance with the Revolving Facility's leverage and interest coverage ratios given the high debt load ($763M).
- Restructuring Progress: Monitor the execution of the $13.8 million restructuring reserve, specifically the closure of facilities in Italy, Russia, and Tennessee.
- Raw Material Costs: Confirm the ability to contain production cost increases to the 10–12% range despite rising premium needle coke prices.
- Asset Sales: Track the status of assets classified as "held for sale" (Etoy, Switzerland and Caserta, Italy) to ensure they are sold at anticipated values.
- Antitrust Exposure: Review updates on foreign customer lawsuits related to historical antitrust investigations, as the company is not currently reserved for these matters.